Team [TISI] vs Lichen China [LICN] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Team Inc. wins in 9 metrics, Lichen China Ltd. wins in 7 metrics, with 0 ties. Team Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Team Inc. | Lichen China Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 0.06 | N/A |
| Price-to-Book Ratio | -3.12 | 0.08 | Lichen China Ltd. |
| Debt-to-Equity Ratio | 1,272.61 | 0.56 | Lichen China Ltd. |
| PEG Ratio | -29.78 | N/A | N/A |
| EV/EBITDA | 9.55 | 1.66 | Lichen China Ltd. |
| Profit Margin (TTM) | -5.49% | -43.20% | Team Inc. |
| Operating Margin (TTM) | 2.97% | -36.80% | Team Inc. |
| EBITDA Margin (TTM) | 2.97% | N/A | N/A |
| Return on Equity | -336.96% | -23.98% | Lichen China Ltd. |
| Return on Assets (TTM) | 1.76% | -10.28% | Team Inc. |
| Free Cash Flow (TTM) | $-20.64M | $-11.51M | Lichen China Ltd. |
| 1-Year Return | -13.65% | -68.90% | Team Inc. |
| Price-to-Sales Ratio (TTM) | 0.09 | 2.78 | Team Inc. |
| Enterprise Value | $462.11M | $-17.34M | Team Inc. |
| EV/Revenue Ratio | 0.52 | -0.46 | Team Inc. |
| Gross Profit Margin (TTM) | 25.94% | N/A | N/A |
| Revenue per Share (TTM) | $199 | $162 | Team Inc. |
| Earnings per Share (Diluted) | $-11.70 | $-71.76 | Team Inc. |
| Beta (Stock Volatility) | 1.02 | -0.47 | Lichen China Ltd. |
| Short % of Float | 0.71% | 0.23% | Lichen China Ltd. |
Team Inc. vs Lichen China Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Team Inc. | 10.39% | 5.46% | -1.68% | 19.97% | 12.14% | 19.47% |
| Lichen China Ltd. | 5.92% | 36.44% | -62.30% | -48.89% | -46.15% | -44.67% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Team Inc. | -13.65% | 138.26% | -81.68% | -94.66% | -92.63% | -89.90% |
| Lichen China Ltd. | -68.90% | -19.05% | -62.68% | -62.68% | -62.68% | -62.68% |
Performance & Financial Health Analysis: Team Inc. vs Lichen China Ltd.
| Metric | TISI | LICN |
|---|---|---|
| Market Information | ||
| Market Cap | $76.71M | $98.78M |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 4,689 | 42,610 |
| 90 Day Avg. Volume | 7,917 | 57,957 |
| Last Close | $17.00 | $1.61 |
| 52 Week Range | $12.34 - $21.33 | $0.75 - $9.49 |
| % from 52W High | -20.30% | -83.04% |
| All-Time High | $480.90 (Jan 13, 2014) | $18.00 (Feb 17, 2025) |
| % from All-Time High | -96.46% | -91.06% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.05% | -0.21% |
| Quarterly Earnings Growth | 0.05% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | -0.05% | -0.43% |
| Operating Margin (TTM) | 0.03% | -0.37% |
| Return on Equity (TTM) | -3.37% | -0.24% |
| Debt to Equity (MRQ) | 1,272.61 | 0.56 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-5.40 | $84.34 |
| Cash per Share (MRQ) | $3.97 | $29.63 |
| Operating Cash Flow (TTM) | $-11,348,000 | $-11,113,000 |
| Levered Free Cash Flow (TTM) | $-17,296,000 | $540,200 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Team Inc. vs Lichen China Ltd.
| Metric | TISI (Apr 24, 2026) | LICN (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 0.06 |
| Forward P/E | -29.78 | N/A |
| PEG Ratio | -29.78 | N/A |
| Price to Sales (TTM) | 0.09 | 2.78 |
| Price to Book (MRQ) | -3.12 | 0.08 |
| Market Capitalization | ||
| Market Capitalization | $76.71M | $98.78M |
| Enterprise Value | $462.11M | $-17,340,320 |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.52 | -0.46 |
| Enterprise to EBITDA | 9.55 | 1.66 |
| Risk & Other Metrics | ||
| Beta | 1.02 | -0.47 |
| Book Value per Share (MRQ) | $-5.40 | $84.34 |
Financial Statements Comparison: Team Inc. vs Lichen China Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | TISI (2025) | LICN (2024) |
|---|---|---|
| Revenue/Sales | 896.48M | 41.48M |
| Cost of Goods Sold | 664.78M | 15.80M |
| COGS % of Revenue | 74.2% | 38.1% |
| Gross Profit | 231.71M | 25.67M |
| Gross Margin | 25.8% | 61.9% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 14.07M | -4.55M |
| Operating Margin | 1.6% | -11.0% |
| EBITDA | 45.26M | -1.68M |
| EBITDA Margin | 5.0% | -4.0% |
| Pre-Tax Income | -46.63M | -4.17M |
| Pre-Tax Income % of Revenue | -5.2% | -10.1% |
| Income Tax | 2.58M | 1.95M |
| Income Tax % of Revenue | 0.3% | 4.7% |
| Net Income (Profit) | -49.21M | -6.12M |
| Profit Margin | -5.5% | -14.8% |
Balance Sheet & Liquidity Metrics
| Metric | TISI (2025) | LICN (2024) |
|---|---|---|
| Cash & Equivalents | 18.15M | 26.71M |
| Total Current Assets | 266.41M | 34.01M |
| Total Current Assets % of Revenue | 29.7% | 82.0% |
| Total Current Liabilities | 120.06M | 4.27M |
| Total Current Liabilities % of Revenue | 13.4% | 10.3% |
| Long-Term Debt | 329.25M | 5,000 |
| Long-Term Debt % of Revenue | 36.7% | 0.0% |
| Total Shareholders Equity | -24.48M | 75.57M |
| Retained Earnings | -464.88M | 42.08M |
| Retained Earnings % of Revenue | -51.9% | 101.5% |
| Property, Plant & Equipment | 49.85M | 61,000 |
Cash Flow Statement Comparison
| Metric | TISI (2025) | LICN (2024) |
|---|---|---|
| Operating Cash Flow | -10.41M | 493,000 |
| Operating Cash Flow % of Revenue | -1.2% | 1.2% |
| Capital Expenditures | N/A | -36,000 |
| Free Cash Flow | -20.64M | -11.51M |
| FCF Margin | -2.3% | -27.7% |
| Debt Repayment | -413.27M | 0 |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | TISI | LICN |
|---|---|---|
| Shares Short | 20,328 | 37,368 |
| Short Ratio | 2.68 | 0.86 |
| Short % of Float | 0.71% | 0.23% |
| Shares Outstanding | 4.53M | 761,825 |
| Float Shares | 2.64M | 756,690 |
| % Held by Insiders | 5.72% | 0.00% |
| % Held by Institutions | 60.57% | 0.00% |
| % Held by Public | 33.71% | 100.00% |
Dividend Analysis & Yield Comparison: Team Inc. vs Lichen China Ltd.
| Metric | TISI | LICN |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | $0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |